Elaidic acid (EA) generates dysfunctional high-density lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish

Molecular Nutrition and Food Research

Volumn 58, Issue 7, 2014, Pages 1537-1545

  Park, Ki Hoon ^a   Kim, Jong Min ^a   Cho, Kyung Hyun ^a  

^a Yeungnam University   (South Korea)

Author keywords

Atherosclerosis; Elaidic acid; Embryo; HDL; Trans fatty acid; Zebrafish

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; ELAIDIC ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OLEIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; STEARIC ACID; STEARIC ACID DERIVATIVE; TRANS FATTY ACID; TRIACYLGLYCEROL;

ANIMAL; ANIMAL EMBRYO; ATHEROSCLEROSIS; BLOOD; CELL CULTURE; DRUG EFFECTS; EMBRYOLOGY; FATTY LIVER; HUMAN; HYPERLIPIDEMIAS; MACROPHAGE; METABOLISM; PATHOLOGY; TOXICITY TESTING; ZEBRA FISH;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; CELLS, CULTURED; CHOLESTEROL ESTER TRANSFER PROTEINS; EMBRYO, NONMAMMALIAN; FATTY LIVER; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MACROPHAGES; OLEIC ACID; REACTIVE OXYGEN SPECIES; STEARIC ACIDS; TOXICITY TESTS, ACUTE; TRANS FATTY ACIDS; TRIGLYCERIDES; ZEBRAFISH;

EID: 84903534961     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300955     Document Type: Article

References (36)

1. Teegala, S. M., Willett, W. C., Mozaffarian, D., Consumption and health effects of trans fatty acids: a review. J. AOAC. Int. 2009, 92, 1250-1257.
2. Butt, M. S., Sultan, M. T., Levels of trans fats in diets consumed in developing economies. J. AOAC. Int. 2009, 92, 1277-1283.
3. Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J. et al., Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354, 1601-1613.
4. Bendsen, N. T., Christensen, R., Bartels, E. M., Astrup, A., Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur. J. Clin. Nutr. 2011. 65, 773-783.
5. Abbey, M., Nestel, P. J., Plasma cholesteryl ester transfer protein activity is increased when trans-elaidic acid is substituted for cis-oleic acid in the diet. Atherosclerosis 1994, 106, 99-107.
6. van Tol, A., Zock, P. L., van Gent, T., Scheek, L. M. et al., Dietary trans fatty acids increase serum cholesterylester transfer protein activity in man. Atherosclerosis 1995, 115, 129-134.
7. Aronis, K. N., Khan, S. M., Mantzoros, C. S., Effects of trans fatty acids on glucose homeostasis: a meta-analysis of randomized, placebo-controlled clinical trials. Am. J. Clin. Nutr. 2012, 96, 1093-1099.
8. Micha, R., Mozaffarian, D., Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat. Rev. Endocrinol. 2009, 5, 335-344.
9. Thompson, A. K., Shaw, D. I., Minihane, A. M., Williams, C. M., Trans-fatty acids and cancer: the evidence reviewed. Nutr. Res. Rev. 2008, 21, 174-188.
10. Hu, J., La, Vecchia, C., de Groh, M., Negri, E. et al., Dietary transfatty acids and cancer risk. Eur. J. Cancer Prev. 2011, 20, 530-538.
11. Carlson, S. E., Clandinin, M. T., Cook, H. W., Emken, E. A. et al., trans fatty acids: infant and fetal development. Am. J. Clin. Nutr. 1997. 66, 715S-736S.
12. Sheila, M. I., Trans fatty intakes during pregnancy, infancy and early childhood. Atheroscler. Suppl. 2006, 7, 17-20.
13. Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M. et al., Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114, 82-96.
14. Fournier, N., Attia, N., Rousseau-Ralliard, D., Vedie, B. et al., Deleterious impact of elaidic fatty acid on ABCA1-mediated cholesterol efflux from mouse and human macrophages. Biochim. Biophys. Acta 2012, 1821, 303-312.
15. Adams, T. H., Walzem, R. L., Smith, D. R., Tseng, S. et al., Hamburger high in total, saturated and trans-fatty acids decreases HDL cholesterol and LDL particle diameter, and increases TAG, in mildly hypercholesterolaemic men. Brit. J. Nutr. 2010, 103, 91-98.
16. Park, K. H., Jang, W., Kim, K. Y., Kim, J. R. et al., Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence. Biochem. Biophys. Res. Commun. 2010, 392, 295-300.
17. Park, K. H., Cho, K. H., High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx. J. Gerontol. A. Biol. Sci. Med. Sci. 2011, 66, 511-520.
18. Hadfield, K. A., Pattison, D. I., Brown, B. E., Hou, L. et al., Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl). Biochem. J. 2013, 449, 531-542.
19. Brewer, H. B. Jr., Ronan, R., Meng, M., Bishop, C., Isolation and characterization of apolipoproteins A-I, A-II, and A-IV. Methods Enzymol. 1986, 128, 223-246.
20. Matz, C. E., Jonas, A., Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 1982, 257, 4535-4540.
21. Cho, K. H., Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration. J. Gerontol. A. Biol. Sci. Med. Sci. 2011, 66, 1274-1285.
22. Staros, J. V., N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 1982, 21, 3950-3955.
23. Chen, Y. H., Yang, J. T., Martinez, H. M., Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 1972, 11, 4120-4131.
24. Esterbauer, H., Striegl, G., Puhl, H., Rotheneder, M., Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 1989, 6, 67-75.
25. Fraenkel-Conrat, H., Methods for investigating the essential groups for enzyme activity. Methods Enzymol. 1957, 4, 247-269.
26. Cho, K. H., Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL. Mol. Cells 2009, 27, 291-297.
27. Markwell, M. A., Haas, S. M., Bieber, L. L., Tolbert, N. E., A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978, 87, 206-210.
28. Han, J. M., Jeong, T. S., Lee, W. S., Choi, I. et al., Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid Res. 2005, 46, 589-596.
29. Park, K. H., Shin, D. G., Kim, J. R., Cho, K. H., Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity. J. Gerontol. A. Biol. Sci. Med. Sci. 2010, 65, 600-610.
30. Nusslein-Volhard, C., Dahm, R., Zebrafish: A Practical Approach, Oxford University Press, Oxford 2002.
31. Park, K. H., Cho, K. H., A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins. Fish Shellfish Immunol. 2011, 31, 904-910.
32. Jin, S., Cho, K. H., Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolpidemic activity in zebrafish. Food Chem. Toxicol. 2011, 49, 1521-1529.
33. Gatto, L. M., Lyons, M. A., Brown, A. J., Samman, S., Trans fatty acids affect lipoprotein metabolism in rats. J. Nutr. 2002, 132, 1242-1248.
34. Khosla, P., Hajri, T., Pronczuk, A., Hayes, K. C., Replacing dietary palmitic acid with elaidic acid (t-C18:1 delta9) depresses HDL and increases CETP activity in cebus monkeys. J. Nutr. 1997, 127, 531S-536S.
35. Gatto, L. M., Sullivan, D. R., Samman, S., Postprandial effects of dietary trans fatty acids on apolipoprotein(a) and cholesteryl ester transfer. Am. J. Clin. Nutr. 2003, 77, 1119-1124.
36. Morton, R. E., Greene, D. J., The capacity of various non-esterified fatty acids to suppress lipid transfer inhibitor protein activity is related to their perturbation of the lipoprotein surface. Biochim. Biophys. Acta 2000, 1486, 275-284.